Back to articles
Comparative guide · 7 min read

Probiotics vs Prebiotics — live bacteria vs the fibre that feeds them

Updated 2026-05-15 · Reviewed by SupplementScore editors · No sponsorships

"Probiotic" and "prebiotic" are often used interchangeably in supplement marketing, but they answer different questions. A probiotic is a live microorganism (typically Lactobacillus, Bifidobacterium, or Saccharomyces species) that transiently passes through your gut. A prebiotic is a fermentable fibre (inulin, FOS, GOS, partially hydrolysed guar gum) that feeds the bacteria you already have. Which is right depends on the symptom, the strain or fibre type, and whether SIBO or fructose intolerance is in play — because prebiotics can absolutely make things worse in the wrong context.

Quick verdict

GoalBetter choiceWhy
Antibiotic-associated diarrhoea preventionProbiotic (specific strains)S. boulardii and Lactobacillus rhamnosus GG have the strongest meta-analytic evidence.
IBS symptom relief — generalProbiotic (multi-strain)Meta-analyses support specific multi-strain products; prebiotic fibres are mixed — some help, FODMAP-rich ones worsen.
Chronic constipationPrebiotic (PHGG, kiwifruit) or psylliumSoluble fibre / prebiotic builds stool; probiotics are unreliable for transit alone.
SIBO or post-meal bloating from FODMAPsNeither — and avoid most prebioticsAdding fermentable substrate to small-bowel overgrowth worsens symptoms; probiotic data in SIBO are mixed.
Long-term microbial diversityPrebiotic (dietary fibre)Higher fibre intake is the most replicable correlate of gut microbial diversity; probiotics rarely colonise persistently.
Cost per day at studied dosePrebiotic (food form)Whole-food prebiotic sources (onions, garlic, leeks, oats, legumes) are essentially free; probiotics run $0.30–1.50/day.

How they actually work

Probiotics — strain-specific, dose-specific, mostly transient

A probiotic is defined as "live microorganisms which, when administered in adequate amounts, confer a health benefit on the host" (WHO/FAO). The clinical evidence is heavily strain-specific: Lactobacillus rhamnosus GG for AAD; Saccharomyces boulardii CNCM I-745 for AAD and C. difficile prevention; Bifidobacterium infantis 35624 for IBS; VSL#3 / Visbiome for ulcerative colitis maintenance. Generic "wide-spectrum 50-billion CFU" products without strain identification have far weaker evidence. Most strains do not colonise long-term; they pass through, exert metabolic effects (short-chain fatty acid production, immune modulation, niche competition with pathogens), and clear within 1–2 weeks of stopping.

Prebiotics — feeding the residents

A prebiotic is "a substrate that is selectively utilised by host microorganisms conferring a health benefit" (ISAPP 2017). The dominant supplement-form prebiotics are inulin (chicory-derived), fructooligosaccharides (FOS), galactooligosaccharides (GOS), and partially hydrolysed guar gum (PHGG). They are fermented in the colon to short-chain fatty acids (acetate, propionate, butyrate) that nourish colonocytes, modulate immune cells, and improve intestinal barrier function. Effects are slower than probiotics — typically 4–8 weeks of daily dosing — and dose-responsive (5–15 g/day for clinical effects).

IBS — strain matters, fibre type matters

For IBS, probiotic evidence is best for specific multi-strain products (Symprove, Visbiome) and for Bifidobacterium infantis 35624. The 2018 BMJ meta-analysis (Ford et al.) supports modest IBS symptom reduction. For prebiotics in IBS, the story is sharper: traditional FOS/inulin can worsen bloating, particularly in IBS-D and SIBO-comorbid cases (they are FODMAPs). Partially hydrolysed guar gum (PHGG) is the IBS-friendlier prebiotic — it ferments more slowly and produces less gas. Psyllium (mixed soluble/insoluble fibre) is technically not a true prebiotic but performs well in IBS-C.

Antibiotic-associated diarrhoea — probiotics' clearest win

The 2017 Cochrane review (Goldenberg et al.) showed probiotics reduce AAD risk by approximately 60%. The best-studied agents are S. boulardii and L. rhamnosus GG, started concurrently with antibiotics and continued for 1–2 weeks after. Take the probiotic ≥2 hours apart from the antibiotic dose. Prebiotics do not have a comparable AAD-prevention dataset.

SIBO and FODMAP-sensitive IBS — the "don't add prebiotics" zone

In SIBO and FODMAP-sensitive IBS, adding fermentable substrate to a small bowel already overgrown with bacteria makes symptoms worse. Inulin, FOS, GOS, and high-FODMAP fibres are best avoided in these contexts until the underlying issue is treated. Probiotic data in SIBO are mixed; some strains (Bacillus coagulans, S. boulardii) appear neutral-to-helpful, while broad-spectrum products may worsen symptoms.

Practical rule. Probiotic for an acute, defined indication: a strain-specific product (S. boulardii or L. rhamnosus GG during antibiotics; B. infantis 35624 or Symprove for IBS) for 4–8 weeks, then reassess. Prebiotic for a long-game gut-microbiome goal: increase dietary fibre to 25–35 g/day from diverse plant sources, or add PHGG / psyllium for constipation. Skip the heavily marketed "synbiotic" stack until you know which problem you're solving.

Dose, form, and timing

Probiotic: Strain-specific dose targeting documented trial doses (CFU varies widely — typically 10–50 billion CFU/day, but B. infantis 35624 is effective at 1 billion). Take with or after food; many strains survive better with food buffer. Refrigerate if label requires.

Prebiotic: 5–15 g/day starting low (2–3 g) and titrating up over 2–3 weeks to allow microbiota adaptation; rushing the dose-escalation causes gas and bloating that resolves with slower titration. PHGG is the easiest-tolerated for IBS users.

Safety

Probiotics: Generally well-tolerated in healthy adults. Avoid in severely immunocompromised patients (rare but documented bacteraemia and fungaemia, particularly S. boulardii in central-line patients). Use caution in pancreatitis (PROPATRIA trial signal for harm in severe acute pancreatitis). Generally compatible with most medications.

Prebiotics: Gas, bloating, and abdominal discomfort are very common during initial titration. Avoid or use PHGG in users with SIBO, FODMAP-sensitive IBS, or post-prandial bloating. Caution at very high doses in users on sotrastaurin or with intestinal stenosis.

Synbiotic combinations

Marketing-driven "synbiotic" stacks combine probiotic strains with their preferred fibre substrate (e.g., L. rhamnosus GG + FOS). Effect is generally additive rather than synergistic in trials. If you want both, consider running them as a paired intervention rather than buying a fixed-ratio synbiotic product whose specific combination has limited trial data.

Who should pick each

Pick a probiotic if: you're starting antibiotics, have IBS with bloating-dominant or mixed symptoms, are managing UC remission, or have post-antibiotic gut dysbiosis. Pick a strain-specific product.

Pick a prebiotic if: you have IBS-C or chronic constipation (PHGG or psyllium), are working on microbial diversity long-term (dietary fibre escalation), or have low fibre intake that you can't easily fix through food alone. Avoid in SIBO and FODMAP-sensitive presentations.

What we'd actually take

For most adults pursuing gut health broadly: 25–35 g/day fibre from diverse plant sources (10+ types of plants per week beats any supplement) and a strain-specific probiotic only for a defined indication. For IBS-C: PHGG 5–10 g/day titrated up over 3 weeks. For an antibiotic course: L. rhamnosus GG or S. boulardii starting day 1 and continuing 1–2 weeks after the course.

Sources

Read more: